507 related articles for article (PubMed ID: 30243491)
1. Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.
Xiong Y; Deng Y; Wang K; Zhou H; Zheng X; Si L; Fu Z
EBioMedicine; 2018 Oct; 36():183-195. PubMed ID: 30243491
[TBL] [Abstract][Full Text] [Related]
2. Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer.
Zhao J; Chang L; Gu X; Liu J; Sun B; Wei X
Cancer Sci; 2020 Aug; 111(8):3020-3031. PubMed ID: 32530556
[TBL] [Abstract][Full Text] [Related]
3. Systematic Analyses of the Differentially Expressed Alternative Splicing Events in Gastric Cancer and Its Clinical Significance.
Lin C; Yu B; Zhang M; Chen Y; Li L; Zhao D
Front Genet; 2020; 11():522831. PubMed ID: 33281863
[TBL] [Abstract][Full Text] [Related]
4. Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance.
Xiong Y; Yang G; Wang K; Riaz M; Xu J; Lv Z; Zhou H; Li Q; Li W; Sun J; Tao T; Li J
Front Genet; 2020; 11():879. PubMed ID: 32849842
[TBL] [Abstract][Full Text] [Related]
5. Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis.
Yao J; Tang YC; Yi B; Yang J; Chai Y; Yin N; Zhang ZX; Wei YJ; Li DC; Zhou J
J Cancer; 2021; 12(11):3164-3179. PubMed ID: 33976726
[TBL] [Abstract][Full Text] [Related]
6. Profiles of alternative splicing events in the diagnosis and prognosis of Gastric Cancer.
Wei C; Xie W; Huang X; Mo X; Liu Z; Wu G; Meng Y; Jeen F; Ge L; Zhang L; Liao L; Liu J; Tang W
J Cancer; 2021; 12(10):2982-2992. PubMed ID: 33854599
[No Abstract] [Full Text] [Related]
7. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
8. Role of alternative splicing events in endometrial cancer prognosis.
Liu J; Mi C; Long W; Sun T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 46(7):680-688. PubMed ID: 34382583
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
[TBL] [Abstract][Full Text] [Related]
11. The landscape of alternative splicing reveals novel events associated with tumorigenesis and the immune microenvironment in gastric cancer.
Lou S; Zhang J; Zhai Z; Yin X; Wang Y; Fang T; Xue Y
Aging (Albany NY); 2021 Jan; 13(3):4317-4334. PubMed ID: 33428603
[TBL] [Abstract][Full Text] [Related]
12. Profiles of prognostic alternative splicing signature in hepatocellular carcinoma.
Wu F; Chen Q; Liu C; Duan X; Hu J; Liu J; Cao H; Li W; Li H
Cancer Med; 2020 Mar; 9(6):2171-2180. PubMed ID: 31975560
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel alternative splicing isoform biomarkers and their association with overall survival in colorectal cancer.
Lian H; Wang A; Shen Y; Wang Q; Zhou Z; Zhang R; Li K; Liu C; Jia H
BMC Gastroenterol; 2020 Jun; 20(1):171. PubMed ID: 32503434
[TBL] [Abstract][Full Text] [Related]
14. Profiles of alternative splicing landscape in breast cancer and their clinical significance: an integrative analysis based on large-sequencing data.
Du JX; Liu YL; Zhu GQ; Luo YH; Chen C; Cai CZ; Zhang SJ; Wang B; Cai JL; Zhou J; Fan J; Dai Z; Zhu W
Ann Transl Med; 2021 Jan; 9(1):58. PubMed ID: 33553351
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide profiling of alternative splicing in glioblastoma and their clinical value.
Li Y; Guo D
BMC Cancer; 2021 Aug; 21(1):958. PubMed ID: 34445990
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Colorectal Cancer-Associated Alternative Splicing Based on Transcriptome.
Zhang J; Deng Y; Zuo Y; Wang J; Zhao Y
DNA Cell Biol; 2020 Jan; 39(1):16-24. PubMed ID: 31808724
[TBL] [Abstract][Full Text] [Related]
17. Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.
Zhang D; Duan Y; Wang Z; Lin J
Oncol Rep; 2019 Dec; 42(6):2450-2472. PubMed ID: 31578577
[TBL] [Abstract][Full Text] [Related]
18. Systematic profiling of alternative splicing in
Liu C; Hu C; Li Z; Feng J; Huang J; Yang B; Wen T
Cancer Cell Int; 2020; 20():279. PubMed ID: 32617077
[TBL] [Abstract][Full Text] [Related]
19. Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.
Chang YS; Tu SJ; Chiang HS; Yen JC; Lee YT; Fang HY; Chang JG
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33142748
[TBL] [Abstract][Full Text] [Related]
20. Deciphering alternative splicing events and their therapeutic implications in colorectal Cancer.
Ding W; Xiao Q; Yue Y; Chen S; She X; Pan B; Zhou L; Yin Y; Li Y; Wang S; Xu M
Cell Signal; 2024 Jun; 118():111134. PubMed ID: 38484942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
